This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Soner Altiok
Introduction
Soner Altiok is a prominent inventor based in Tampa, FL (US), known for his significant contributions to cancer research. With a total of 3 patents, he has made strides in the field of oncology, particularly in distinguishing various types of carcinomas.
Latest Patents
Altiok's latest patents include groundbreaking methods that enhance the diagnosis of cancer. One notable patent is a method of distinguishing lung squamous cell carcinoma from head and neck squamous cell carcinoma. This method utilizes a 22-gene biomarker signature to improve diagnostic accuracy. Another important patent focuses on distinguishing urothelial carcinoma from lung and head and neck squamous cell carcinoma. This innovation presents a 19-gene signature that differentiates between metastatic urothelial carcinoma and squamous cell carcinoma, regardless of whether the primary site is known or unknown.
Career Highlights
Soner Altiok is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he conducts his research. His work is pivotal in advancing cancer diagnostics and treatment methodologies. His innovative approaches have the potential to significantly impact patient outcomes in oncology.
Collaborations
Altiok collaborates with esteemed colleagues in his field, including Yin Xiong and Anthony M Magliocco. These partnerships enhance the research efforts and contribute to the development of effective cancer treatment strategies.
Conclusion
Soner Altiok's contributions to cancer research through his patents and collaborations underscore his commitment to improving diagnostic methods in oncology. His work continues to pave the way for advancements in cancer treatment and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
